| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2024-09-11 20:29:15 UTC |
|---|
| Updated at | 2024-09-11 20:29:15 UTC |
|---|
| NP-MRD ID | NP0339220 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | beta-Citryl-L-glutamic acid |
|---|
| Description | Beta-Citryl-L-glutamic acid is also known as b-citryl-L-glutamate. beta-Citryl-L-glutamic acid was first documented in 2018 (PMID: 30197481). Based on a literature review very few articles have been published on beta-Citryl-L-glutamic acid (PMID: 31110199). |
|---|
| Structure | OC(=O)CCC(NC(=O)C(O)(CC(O)=O)CC(O)=O)C(O)=O InChI=1/C11H15NO10/c13-6(14)2-1-5(9(19)20)12-10(21)11(22,3-7(15)16)4-8(17)18/h5,22H,1-4H2,(H,12,21)(H,13,14)(H,15,16)(H,17,18)(H,19,20) |
|---|
| Synonyms | | Value | Source |
|---|
| b-Citryl-L-glutamate | Generator | | b-Citryl-L-glutamic acid | Generator | | beta-Citryl-L-glutamate | Generator | | Β-citryl-L-glutamate | Generator | | Β-citryl-L-glutamic acid | Generator |
|
|---|
| Chemical Formula | C11H15NO10 |
|---|
| Average Mass | 321.2380 Da |
|---|
| Monoisotopic Mass | 321.06960 Da |
|---|
| IUPAC Name | 2-[3-carboxy-2-(carboxymethyl)-2-hydroxypropanamido]pentanedioic acid |
|---|
| Traditional Name | 2-[3-carboxy-2-(carboxymethyl)-2-hydroxypropanamido]pentanedioic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | OC(=O)CCC(NC(=O)C(O)(CC(O)=O)CC(O)=O)C(O)=O |
|---|
| InChI Identifier | InChI=1/C11H15NO10/c13-6(14)2-1-5(9(19)20)12-10(21)11(22,3-7(15)16)4-8(17)18/h5,22H,1-4H2,(H,12,21)(H,13,14)(H,15,16)(H,17,18)(H,19,20) |
|---|
| InChI Key | GAQNUGISBQJMKO-UHFFFAOYNA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | This compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Glutamic acid and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Glutamic acid or derivatives
- N-acyl-alpha-amino acid
- Tetracarboxylic acid or derivatives
- N-acyl-alpha amino acid or derivatives
- Fatty amide
- N-acyl-amine
- Fatty acyl
- Tertiary alcohol
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid
- Alcohol
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Zhao J, Jung YH, Jin Y, Kang S, Jang CG, Lee J: A comprehensive metabolomics investigation of hippocampus, serum, and feces affected by chronic fluoxetine treatment using the chronic unpredictable mild stress mouse model of depression. Sci Rep. 2019 May 20;9(1):7566. doi: 10.1038/s41598-019-44052-2. [PubMed:31110199 ]
- Tsai CK, Yeh TS, Wu RC, Lai YC, Chiang MH, Lu KY, Hung CY, Ho HY, Cheng ML, Lin G: Metabolomic alterations and chromosomal instability status in gastric cancer. World J Gastroenterol. 2018 Sep 7;24(33):3760-3769. doi: 10.3748/wjg.v24.i33.3760. [PubMed:30197481 ]
|
|---|